Statin use is associated with the reduction in hepatocellular carcinoma recurrence after liver surgery

BACKGROUND: Hepatocellular carcinoma (HCC) is the sixth most common form of cancer worldwide. Although surgical treatments have an acceptable cure rate, tumor recurrence is still a challenging issue. In this meta-analysis, we investigated whether statins prevent HCC recurrence following liver surger...

Descripción completa

Detalles Bibliográficos
Autores principales: Khajeh, Elias, Moghadam, Arash Dooghaie, Eslami, Pegah, Ali-Hasan-Al-Saegh, Sadeq, Ramouz, Ali, Shafiei, Saeed, Ghamarnejad, Omid, Dezfouli, Sepehr Abbasi, Rupp, Christian, Springfeld, Christoph, Carvalho, Carlos, Probst, Pascal, Mousavizadeh, Seyed Mostafa, Mehrabi, Arianeb
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781082/
https://www.ncbi.nlm.nih.gov/pubmed/35062904
http://dx.doi.org/10.1186/s12885-022-09192-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781082/
https://www.ncbi.nlm.nih.gov/pubmed/35062904
http://dx.doi.org/10.1186/s12885-022-09192-1

Ejemplares similares